Vyvanse / Lisdexamfetamine → New Zealand

Vyvanse / Lisdexamfetamine may require documentation or declaration

Details

Lisdexamfetamine (Vyvanse/Elvanse) is classified as an amphetamine derivative and is prohibited in Japan regardless of prescription status — no import permit pathway exists for personal use. China, South Korea, and most of Southeast Asia prohibit or. Enforcement in New Zealand carries fines from NZD 400 to NZD 5,000 under Biosecurity Act 1993 s.157, s.155; Customs and Excise Act 2018 (typical personal cases are handled as civil infringements).

Quantity limit

Up to 3-month personal supply under Misuse of Drugs Act 1975 personal exemption

Documentation required

• Original prescription from licensed physician
• Medication in original pharmacy-labelled packaging
• Doctor's letter (strongly recommended)

Leaving with this item

Vyvanse (lisdexamfetamine) is a controlled stimulant; personal export from New Zealand requires prescription documentation and stays within personal-use limits.

Practical advice

Carry documentation. Declare proactively at customs. If unsure, declare on arrival — declared goods at worst attract duty or surrender, while undeclared goods found in screening are seized and fined.

Customs authority

New Zealand Customs Service (NZCS) · https://www.customs.govt.nz